Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology

Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes

Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum

Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting